Journal of the American College of Cardiology




One-year access to more than 500 world journals available in the system
    http://medilib.ir
  • Duration of Time : 365 Day
  • Price : 300$
  • Special Price : 100$
Order

Audio Summary

doi : 10.1016/S0735-1097(21)05858-7

Volume 78, Issue 11, 14 September 2021, Page e65

Buy The Package and View The Article Online


Contents

doi : 10.1016/S0735-1097(21)05940-4

Volume 78, Issue 12, 21 September 2021, Pages e77-e80

Buy The Package and View The Article Online


Healthy Sleep Patterns and Risk of Incident Arrhythmias

XiangLiMD, PhDaTaoZhouMD, PhDabHaoMaPhDaTaoHuangPhDcXiangGaoMD, PhDdJoAnn E.MansonDrPH, MDefgLuQiMD, PhDah

doi : 10.1016/j.jacc.2021.07.023

Volume 78, Issue 12, 21 September 2021, Pages 1197-1207

Emerging evidence has linked sleep behaviors with the risk of cardiac arrhythmias. The various sleep behaviors are typically correlated; however, most of the previous studies only focused on the individual sleep behavior, without considering the overall sleep patterns.

Buy The Package and View The Article Online


Sleep Patterns and Arrhythmias: Should This Keep Us Awake at Night??

AlanKadishMDJasonJacobsonMD

doi : 10.1016/j.jacc.2021.07.024

Volume 78, Issue 12, 21 September 2021, Pages 1208-1209

Buy The Package and View The Article Online


Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment

James P.HowardPhDa?Frances A.WoodMPhila?Judith A.FinegoldPhDaAlexandra N.NowbarMBBSaDavid M.ThompsonPhDaAhran D.ArnoldMBBSaChristopher A.RajkumarMBBSaSusanConnollyPhDaJaiminiCeglaPhDbChrisStridePhDcPeterSeverPhDaChristineNortonPhDdSimon A.M.ThomMDaMatthew J.Shun-ShinPhDaDarrel P.FrancisMAa

doi : 10.1016/j.jacc.2021.07.022

Volume 78, Issue 12, 21 September 2021, Pages 1210-1222

Most people who begin statins abandon them, most commonly because of side effects.

Buy The Package and View The Article Online


That Myalgia of Yours Is Not From Statin Intolerance?

Peter P.TothMD, PhD

doi : 10.1016/j.jacc.2021.07.025

Volume 78, Issue 12, 21 September 2021, Pages 1223-1226

Buy The Package and View The Article Online


External Validation of the SYNTAX Score II 2020

HironoriHaraMDabcHirokiShiomiMDdDavidvan KlaverenPhDefDavid M.KentMD, MSfEwout W.SteyerbergPhDgScotGargMD, PhDhYoshinobuOnumaMD, PhDbTakeshiKimuraMDdPatrick W.SerruysMD, PhDbi

doi : 10.1016/j.jacc.2021.07.027

Volume 78, Issue 12, 21 September 2021, Pages 1227-1238

The SYNTAX score II 2020 (SSII-2020) was derived from cross correlation and externally validated in randomized trials to predict death and major adverse cardiac and cerebrovascular events (MACE) following percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with 3-vessel disease (3VD) and/or left main coronary artery disease (LMCAD).

Buy The Package and View The Article Online


SYNTAX Score II 2020: A Remake Worth the Price of Admission??

John J.SquiersMDabJ. MichaelDiMaioMDa

doi : 10.1016/j.jacc.2021.07.028

Volume 78, Issue 12, 21 September 2021, Pages 1239-1241

Buy The Package and View The Article Online


Hospitalizations and Outcomes of T1MI Observed Before and After the Introduction of MI Subtype Codes

Cian P.McCarthyMB, BCh, BAOaDhavalKolteMD, PhDaKevin F.KennedyMSaAmbarishPandeyMDbInbarRaberMDcAndrewOseranMD, MBAaRishi K.WadheraMD, MPP, MPhilcdMuthiahVaduganathanMD, MPHeJames L.JanuzziJr.MDaJason H.WasfyMD, MPhila

doi : 10.1016/j.jacc.2021.07.034

Volume 78, Issue 12, 21 September 2021, Pages 1242-1253

International Classification of Disease (ICD)-10 coding of type 1 myocardial infarction (MI) is used for reimbursement, value-based programs, and clinical research.

Buy The Package and View The Article Online


Impact of New ICD Codes on Acute MI Characteristics and Outcomes: What You Call It Matters?

Andrew P.DeFilippisMD, MScaMichael E.HallMD, MScb

doi : 10.1016/j.jacc.2021.07.033

Volume 78, Issue 12, 21 September 2021, Pages 1254-1256

Buy The Package and View The Article Online


Optical Coherence Tomography of Plaque Vulnerability and Rupture: JACC Focus Seminar Part 1/3

Aaron D.AguirreMD, PhDabcArminArbab-ZadehMD, PhDdTsunenariSoedaMD, PhDeValentinFusterMD, PhDfgIk-KyungJangMD, PhDah

doi : 10.1016/j.jacc.2021.06.050

Volume 78, Issue 12, 21 September 2021, Pages 1257-1265

Plaque rupture is the most common cause of acute coronary syndromes and sudden cardiac death. Characteristics and pathobiology of vulnerable plaques prone to plaque rupture have been studied extensively over 2 decades in humans using optical coherence tomography (OCT), an intravascular imaging technique with micron scale resolution. OCT studies have identified key features of plaque vulnerability and described the in vivo characteristics and spatial distribution of thin cap fibroatheromas as major precursors to plaque rupture. In addition, OCT data supports the evolving understanding of coronary heart disease as a panvascular process associated with inflammation. In the setting of high atherosclerotic burden, plaque ruptures often occur at multiple sites in the coronary arteries, and plaque progression and healing are dynamic processes modulated by systemic risk factors. This review details major investigations with intravascular OCT into the biology and clinical implications of plaque vulnerability and plaque rupture.

Buy The Package and View The Article Online


Optical Coherence Tomography of Plaque Erosion: JACC Focus Seminar Part 2/3

DhavalKolteMD, PhDaTaishiYonetsuMD, PhDbJong ChulYePhDcPeterLibbyMDdValentinFusterMD, PhDefIk-KyungJangMD, PhDag

doi : 10.1016/j.jacc.2021.07.030

Volume 78, Issue 12, 21 September 2021, Pages 1266-1274

Plaque erosion, a distinct histopathological and clinical entity, accounts for over 30% of acute coronary syndromes (ACS). Optical coherence tomography allows in vivo diagnosis of plaque erosion. Local flow perturbation with activation of Toll-like receptor 2 and CD8+ T cells and subsequent desquamation of endothelium and neutrophil extracellular trap formation contribute to mechanisms of plaque erosion. Compared with ACS patients with plaque rupture, those with plaque erosion are younger, have fewer traditional cardiovascular risk factors, have lower plaque burden, and are more likely to present with non–ST-segment elevation ACS. Early evidence suggests that in patients with ACS caused by plaque erosion, antithrombotic therapy without stenting may be a safe and effective option. Future randomized trials are needed to validate these findings. Clinical studies to develop noninvasive point-of-care biomarkers that distinguish plaque rupture from erosion, and to test novel therapies that target molecular pathways involved in plaque erosion are needed.

Buy The Package and View The Article Online


Optical Coherence Tomography of Coronary Plaque Progression and Destabilization: JACC Focus Seminar Part 3/3

TomAdriaenssensMD, PhDa?Marc P.Allard-RatickMDb?VikasThondapuMD, PhDc?TomoyoSugiyamaMD, PhDdO. ChristopherRaffelMD, PhDePeterBarlisMD, PhDfEric K.W.PoonPhDfMakotoArakiMD, PhDbAkihiroNakajimaMDbYoshiyasuMinamiMD, PhDgMasamichiTakanoMD, PhDhOsamuKuriharaMD, PhDhValentinFusterMD, PhDijTsunekazuKakutaMD, PhDdIk-KyungJangMD, PhDbk

doi : 10.1016/j.jacc.2021.07.032

Volume 78, Issue 12, 21 September 2021, Pages 1275-1287

The development of optical coherence tomography (OCT) has revolutionized our understanding of coronary artery disease. In vivo OCT research has paralleled with advances in computational fluid dynamics, providing additional insights in the various hemodynamic factors influencing plaque growth and stability. Recent OCT studies introduced a new concept of plaque healing in relation to clinical presentation. In addition to known mechanisms of acute coronary syndromes such as plaque rupture and plaque erosion, a new classification of calcified plaque was recently reported. This review will focus on important new insights that OCT has provided in recent years into coronary plaque development, progression, and destabilization, with a focus on the role of local hemodynamics and endothelial shear stress, the layered plaque (signature of previous subclinical plaque destabilization and healing), and the calcified culprit plaque.

Buy The Package and View The Article Online


PCSK9 Inhibition and Oxidized Phospholipids

Harpreet S.BhatiaMDCalvinYeangMD, PhDAmosBaruchPhDXiaohongYangBSErik S.G.StroesMD, PhDSotiriosTsimikasMD

doi : 10.1016/j.jacc.2021.07.031

Volume 78, Issue 12, 21 September 2021, Pages 1288-1289

Buy The Package and View The Article Online


Do you want to add Medilib to your home screen?